OÜ Tervisetestid

14164739

General info

Name

OÜ Tervisetestid

Registry code

14164739

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

07.12.2016 (7)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

86909 - Other healthcare activities not classified elsewhere

Revenue

222 301 €

Profit

33 627 €

Profit margin

15%

Gross salary

936 €

(estimate is approximate)

Equity

22 445 €

Employees

7

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

150%

Return on assets

76%

Related parties

Owner Representative Beneficial owner Roles

Nele-Triin Lott

30.07.1967 (57)

100% - 2 500.00 EUR Board member Direct ownership Founder

Kaarel Lott

26.01.1997 (27)

- Board member -

Financial info

2019
30.06.2020
2020
29.06.2021
2021
28.06.2022
2022
19.06.2023
2023
22.03.2024
Total Revenue 39 344 € 25 597 € 57 526 € 142 632 € 222 301 €
Net profit (loss) for the period 3 651 € -5 299 € -4 160 € 13 660 € 33 627 €
Profit Margin 9% -21% -7% 10% 15%
Current Assets 3 535 € 1 172 € 10 602 € 23 192 € 39 701 €
Fixed Assets 5 411 € 3 502 € 1 593 € 1 671 € 4 731 €
Total Assets 8 946 € 4 674 € 12 195 € 24 863 € 44 432 €
Current Liabilities 24 329 € 25 356 € 37 037 € 36 045 € 21 987 €
Non Current Liabilities - - - - -
Total Liabilities - - - - -
Share Capital - - - - -
Equity -15 383 € -20 682 € -24 842 € -11 182 € 22 445 €
Employees 3 4 6 6 7

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 - 14 502.86 € 12 818.92 € 12
2023 Q4 - 12 106.95 € 12 906.74 € 9
2023 Q3 - 7 700.07 € 8 248.57 € 9
2023 Q2 - 7 816.65 € 8 407.85 € 9
2023 Q1 - 7 575.04 € 8 079.68 € 10
2022 Q4 - 5 335.39 € 5 752.22 € 10
2022 Q3 - 4 258.9 € 4 414.94 € 10
2022 Q2 - 3 670.26 € 3 945.56 € 10
2022 Q1 - 3 998.18 € 4 302.68 € 9
2021 Q4 - 2 042.21 € 2 196.32 € 9
2021 Q3 - 1 437.54 € 1 545.18 € 9
2021 Q2 - 1 306.39 € 1 391.62 € 9
2021 Q1 - 836.17 € 893.92 € 9
2020 Q4 - 846.74 € 906.19 € 9
2020 Q3 - 570.13 € 609.57 € 9
2020 Q2 - 424.66 € 455.82 € 9
2020 Q1 - 1 228.02 € 1 324.16 € 8